4//SEC Filing
HOBDEN ADRIAN N 4
Accession 0001181431-10-017445
CIK 0001459450other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:20 PM ET
Size
5.2 KB
Accession
0001181431-10-017445
Insider Transaction Report
Form 4
HOBDEN ADRIAN N
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2010-03-18$4.41/sh+20,000$88,200→ 134,782 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.45 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Myriad Pharmaceuticals, Inc.
CIK 0001459450
Entity typeother
Related Parties
1- filerCIK 0001191076
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:20 PM ET
- Size
- 5.2 KB